These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 2743717)

  • 1. C-1 inhibitor activity levels in active rheumatoid and psoriatic arthritis.
    Maqaro M; Altomonte L; Zoli A; Mirone L; Berchicci M; Corvino G
    Clin Rheumatol; 1989 Mar; 8(1):114-5. PubMed ID: 2743717
    [No Abstract]   [Full Text] [Related]  

  • 2. The concentrations of the fourth component of complement and of the C1 inactivator in synovial fluid from arthritic patients.
    Hedberg H; Laurell AB
    Clin Exp Immunol; 1972 Jun; 11(2):201-7. PubMed ID: 5040309
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Terminal complement complexes and C1/C1 inhibitor complexes in rheumatoid arthritis and other arthritic conditions.
    Oleesky DA; Daniels RH; Williams BD; Amos N; Morgan BP
    Clin Exp Immunol; 1991 May; 84(2):250-5. PubMed ID: 2025952
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Serum anti-immunoglobulins in psoriatic arthritis as compared with rheumatoid arthritis.
    Tapanes FJ; Rawson AJ; Hollander JL
    Arthritis Rheum; 1972; 15(2):153-6. PubMed ID: 4623832
    [No Abstract]   [Full Text] [Related]  

  • 5. Immunological studies on synovial joint membranes in psoriatic arthritis.
    Fyrand O
    Acta Derm Venereol Suppl (Stockh); 1979; 87():15-20. PubMed ID: 394545
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immunofluorescence studies for immunoglobulins and complement C3 in synovial joint membranes in psoriatic arthritis.
    Fyrand O; Mellbye OJ; Natvig JB
    Clin Exp Immunol; 1977 Sep; 29(3):422-7. PubMed ID: 338220
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Autoimmunity to collagen: a shared feature of psoriatic and rheumatoid arthritis.
    Trentham DE; Kammer GM; McCune WJ; David JR
    Arthritis Rheum; 1981 Nov; 24(11):1363-9. PubMed ID: 7032530
    [No Abstract]   [Full Text] [Related]  

  • 8. [Synovial level of interleukin 1 and C3a in chronic polyarthritis, psoriatic arthritis and activated arthritis].
    Hermann E; Vogt P; Hagmann W; Dunky A; Müller W
    Z Rheumatol; 1988; 47(1):20-5. PubMed ID: 3259355
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Etiopathogenetic aspects of psoriatic arthritis with special reference to immunologic factors].
    Hein G; Henzgen M; Vogelsang H; Knopf B
    Z Gesamte Inn Med; 1984 Nov; 39(21):537-9. PubMed ID: 6240837
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Nitroblue tetrazolium test in psoriatic arthritis, rheumatoid arthritis, and osteoarthrosis.
    Lambert JR; Roberts M; Wright V
    Ann Rheum Dis; 1978 Aug; 37(4):363-5. PubMed ID: 686869
    [TBL] [Abstract][Full Text] [Related]  

  • 11. High levels of antipeptidoglycan antibodies in psoriatic and other seronegative arthritides.
    Rahman MU; Ahmed S; Schumacher HR; Zeiger AR
    J Rheumatol; 1990 May; 17(5):621-5. PubMed ID: 2359072
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Histocompatibility antigens in psoriatic and seronegative rheumatoid arthritis].
    Benevolenskaia LI; Erdes Sh; Iakovleva DB; Groppa LP
    Ter Arkh; 1986; 58(7):17-9. PubMed ID: 3764734
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cell-mediated immunity in psoriatic arthritis.
    Espinoza LR; Gaylord SW; Vasey FB; Osterland CK
    J Rheumatol; 1980; 7(2):218-24. PubMed ID: 6966333
    [TBL] [Abstract][Full Text] [Related]  

  • 14. IgG antiglobulin levels in patients with psoriatic arthropathy, ankylosing spondylitis, and gout.
    Howell FA; Chamberlain MA; Perry RA; Torrigiani G; Roitt IM
    Ann Rheum Dis; 1972 Mar; 31(2):129-31. PubMed ID: 4536959
    [No Abstract]   [Full Text] [Related]  

  • 15. Rheumatoid factors in psoriatic arthropathy and in Waaler-Rose negative rheumatoid arthritis.
    Tarkowski A; Nilsson LA
    Rheumatol Int; 1984; 4(3):115-7. PubMed ID: 6463523
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Anticardiolipin antibodies in patients with rheumatic diseases.
    Fort JG; Cowchock FS; Abruzzo JL; Smith JB
    Arthritis Rheum; 1987 Jul; 30(7):752-60. PubMed ID: 3619960
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Increased plasma concentrations of complement modulating proteins (C1 inhibitor, C4-binding protein, factor H and factor I) in psoriasis.
    Ohkohchi K; Torinuki W; Tagami H
    Tohoku J Exp Med; 1988 Apr; 154(4):315-21. PubMed ID: 2973157
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Psoriasis arthropathica and seronegative rheumatoid arthritis--differential diagnostic considerations].
    Schulze P; Loreck D; Hüge H; Hüge W
    Z Gesamte Inn Med; 1984 Jun; 39(11):253-7. PubMed ID: 6332432
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Italian perspective on psoriasis, spondyloarthritis, rheumatoid arthritis and juvenile idiopathic arthritis: immunopathology and role of etanercept. Abstracts of a Seminars in Research. October 14-15, 2011. Italy.
    Clin Drug Investig; 2013 Aug; 33 Suppl 2():59-139. PubMed ID: 24404571
    [No Abstract]   [Full Text] [Related]  

  • 20. [Demonstration of increased influenza-A-antibody levels in the serum of patients with chronic polyarthritis].
    Wruck K; Zöller B; Faust-Tinnefeldt G; Engel HJ
    Z Rheumatol; 1985; 44(6):259-62. PubMed ID: 4096127
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.